EGIRAMLON 5MG/10 MG CPS DUR 60

What is the maximum co-payment for EGIRAMLON?

If the insurance company contributes, the maximum co-payment is 0,00 Kč. The maximum pharmacy price is 337,14 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but the reimbursement conditions (reporting limit) have not been set.

Does EGIRAMLON have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

337,14 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

The medicine has no indication restriction. Its reimbursement is not conditional on a specific diagnosis or clinical condition.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe EGIRAMLON?

Prescription is not conditional on a medical specialization.

What is the composition of EGIRAMLON?

Ramipril (5 mg), amlodipin-besilát (13,9 mg), amlodipin (10 mg), neznámá látka s kódem 17841, hypromelosa, neznámá látka s kódem 20703, neznámá látka s kódem 16007, červený oxid železitý, oxid titaničitý, želatina, neznámá látka s kódem 3793, indigokarmín. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to EGIRAMLON?

The medicine belongs to ATC group C09BB07 – RAMIPRIL A AMLODIPIN. Medicines with the same active substance can be found here.

Who manufactures EGIRAMLON?

Egis Pharmaceuticals PLC, Budapešť (H)

Is the medicine in shortage?

The latest report from the manufacturer is from 1. 12. 2023. Production was terminated with effect from 5. 1. 2024. The manufacturer lists medicines with the following code as a potential substitute: